AVROBIO (AVRO)
(Delayed Data from NSDQ)
$1.23 USD
+0.01 (0.82%)
Updated May 2, 2024 04:00 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
0 items in cart
AVROBIO, Inc. [AVRO]
Reports for Purchase
Showing records 1 - 20 ( 114 total )
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Winding Down and Exploring Alternatives; D/G to Neutral
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
More Consistent Results for Cystinosis Gene Therapy
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
Gaucher Going Well, Seeing Cystinosis in the Second Half
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: AVROBIO, Inc.
Industry: Medical - Biomedical and Genetics
ASGCT 2023 Abstract Roundup For Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D